Microbot Medical Inc. (NASDAQ:MBOT) Stock Holdings Trimmed by Renaissance Technologies LLC

Renaissance Technologies LLC lessened its position in Microbot Medical Inc. (NASDAQ:MBOT) by 64.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 29,295 shares of the biotechnology company’s stock after selling 52,412 shares during the period. Renaissance Technologies LLC’s holdings in Microbot Medical were worth $30,000 at the end of the most recent reporting period.

Separately, Thoroughbred Financial Services LLC acquired a new position in shares of Microbot Medical in the 2nd quarter worth $53,000. 16.30% of the stock is currently owned by institutional investors.

Microbot Medical Trading Down 2.3 %

Shares of MBOT stock opened at $0.96 on Tuesday. Microbot Medical Inc. has a 1-year low of $0.82 and a 1-year high of $2.35. The company has a market capitalization of $15.35 million, a price-to-earnings ratio of -1.08 and a beta of 1.64. The stock’s fifty day simple moving average is $0.94 and its 200-day simple moving average is $1.00.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.17) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.17). On average, sell-side analysts predict that Microbot Medical Inc. will post -0.66 EPS for the current year.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.